Furthermore, the presence of vasculogenic cytokines and growth factors (IL-8, TGF-β, SDF-1α and VEGF) in conditioned medium from MSCs reinforce the beneficial effects for cell therapy of ONFH in SCD patients. The gene discussed is CXCL8; the disease is Schnyder corneal dystrophy.